SI-BONE Inc. (SIBN) Tops Q2 EPS by 10c; Raises FY23 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LITE
6. LYB
7. TFII
8. NVT
9. SPY
10. AAPL

Go back to SI-BONE Inc. (SIBN) Tops Q2 EPS by 10c; Raises FY23 Revenue Guidance

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance

August 7, 2023 4:09 PM EDT

SANTA CLARA, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2023.

Recent Highlights

Record worldwide revenue of $33.3 million for the second quarter 2023, representing approximately 30% growth over the corresponding period in 2022Record U.S. revenue of $31.2 million for the second quarter 2023, representing approximately 31% growth over the corresponding period in... More